Therapy-related acute myelogenous leukemia with an 11q23/mll translocation following adjuvant cisplatin and vinorelbine for non-small-cell lung cancer

Clinical Lung Cancer

Volumn 10, Issue 6, 2009, Pages 438-440

  Faller, Bryan A ^a   Robu, Valentin G ^a   Borghaei, Hossein ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Adenocarcinoma; Cytarabine; Idarubicin; Pseudomonas aeruginosa; Squamous cell carcinoma

Indexed keywords

ACETYLSALICYLIC ACID; CISPLATIN; CYTARABINE; ESCITALOPRAM; FOLIC ACID; IDARUBICIN; METOPROLOL; NAVELBINE; TAMSULOSIN; TIOTROPIUM BROMIDE; ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; MIXED LINEAGE LEUKEMIA PROTEIN; MLL PROTEIN, HUMAN; VINBLASTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AGED; ARTICLE; CASE REPORT; FATIGUE; GENE REARRANGEMENT; GENE TRANSLOCATION; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MALE; CHEMICALLY INDUCED DISORDER; CHROMOSOME 11; DRUG EFFECT; FOLLOW UP; GENETICS; LUNG TUMOR;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOMES, HUMAN, PAIR 11; CISPLATIN; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, MYELOID, ACUTE; LUNG NEOPLASMS; MALE; MYELOID-LYMPHOID LEUKEMIA PROTEIN; TRANSLOCATION, GENETIC; VINBLASTINE;

EID: 74949144313     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2009.n.082     Document Type: Article

References (20)

1. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100:2292-2302
2. Albain KS, Le Beau MM, Ullirsch R, et al. Implication of prior treatment with drug combinations including inhibitors of topoisomerase 11 in therapy-related monocytic leukemia with a 9;11 translocation. Genes Chromosomes Cancer 1990; 2:53-58
3. Brenez D, Devriendt J, Lenclud C, et al. Acute non lymphocytic leukemia following chemotherapy with cisplatin and etoposide for non-small-cell carcinoma of the lung: case report. Cancer Chemother Pharmacol 1990; 26:235-236
4. Pedersen-Bjergaard J, Philip P, Larsen SO, et al. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia 1993; 7:1975-1986
5. Quesnel B, Kantarajian H, Bjergaard JP, et al. Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature. J Clin Oncol 1993; 11:2370-2379
6. Chambers SK, Chopyk RL, Chambers JT, et al. Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer. Cancer 1989; 64:2459-2461
7. Markman M, Hoskins WB. Acute leukemia in a patient with ovarian cancer treated with cisplatin-based chemotherapy and alkeran. Cancer Invest 1990; 8:113-114
8. Martin J, Majumdar G. Platinum compounds and therapy related acute promyelocytic leukemia. Hematol J 2002; 3:321-323
9. Reed E, Evans MK. Acute leukemia following cisplatin-based chemotherapy in a patient with ovarian cancer. J Natl Cancer Inst 1990; 82:431-432
10. Schneider DT, Hilgenfeld E, Schwabe D, et al. Acute myelogenous leukemia after treatment for malignant germ cell tumours in children. J Clin Oncol 1999; 17:3226-3233
11. Sprance HE, Hempling RE, Piver MS. Leukemia following cisplatin-based chemotherapy for ovarian carcinoma at Roswell Park. Eur J Gynaecol Oncol 1992; 13:131-137
12. Wierecky J, Kollmannsberger C, Boehlke I, et al. Secondary leukemia after firstline high-dose chemotherapy for patients with advanced germ cell cancer. J Cancer Res Clin Oncol 2005; 131:255-260
13. Yokoyama Y, Futagami M, Fukushi Y, et al. Secondary acute nonlymphocytic leukemia following successful chemotherapy combining cisplatin, doxorubicin, and cyclophosphamide for stage IV epithelial ovarian cancer. Arch Gynecol Obstet 2000; 263:206-207
14. Bhatia S, Krailo MD, Chen Z, et al. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. Blood 2007; 109:46-51.
15. Detourmignies L, Castaigne S, Stoppa AM, et al. Therapy-related acute promyelocytic leukemia: a report on 16 cases. J Clin Oncol 1992; 10:1430-1435
16. Suehiro Y, Uike N, Kumagawa M, et al. Therapy-related acute myeloid leukemia with minimal myeloid differentiation (AML-M0) associated with a t(11;19)(q23;p13.3) translocation. Am J Hematol 1997; 55:165-166
17. Kolb EA, Steinherz PG. A new multidrug reinduction protocol with topotecan, vinorelbine, thiotepa, dexamethasone, and gemcitabine for relapsed or refractory acute leukemia. Leukemia 2003; 17:1967-1972
18. Uckun FM, Morar S, Qazi S. Vinorelbine-based salvage chemotherapy for therapy-refractory aggressive leukaemias. Br J Haematol 2006; 135:500-508
19. Schoch C, Schnittger S, Klaus M, et al. AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood 2003; 102:2395-2402
20. Bloomfield CD, Archer KJ, Mrózek K, et al. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop. Genes Chromosomes Cancer 2002; 33:362-378 (Pubitemid 34208798)